Sorted By:

Relevance


Seniors Rate Part D Highly on Many Measures

Chartpack  |  From Our Network

Medicare Part D beneficiaries report that their plans are affordable and work well....
http://chartpack.phrma.org/programs-chartpack/medicines-in-medicare/seniors-rate-part-d-highly-on-many-measures

Medicare Monday: New research finds trends in Average Sales Price of Part B drugs remains stable

PhRMA  |  Blog Post

By looking at the larger picture, you can get a more accurate look at drug cost trends.
http://catalyst.phrma.org/medicare-monday-new-research-finds-trends-in-average-sales-price-of-part-b-drugs-remains-stable

Video: How can biomarkers and surrogate endpoints enhance R&D of medicines?

PhRMA  |  Blog Post

A well-defined regulatory pathway for biomarker qualification can help improve drug development, accelerate patient access to promising therapies, open new avenues for research and yield a more competitive and sustainable biopharmaceutical ecosystem.
http://catalyst.phrma.org/video-how-can-biomarkers-and-surrogate-endpoints-enhance-r-and-d-of-medicines

World Anti-Counterfeiting Day Puts Spotlight On Growing Foreign Counterfeit Medicine Threat

PhRMA  |  Press Release

PhRMA companies are leading the way in the search for new cures.
https://www.phrma.org/press-release/world-anti-counterfeiting-day-puts-spotlight-on-growing-foreign-counterfeit-medicine-threat

Print Ad: Hospital Markups

PhRMA  |  Graphic

According to a new analysis, hospitals mark up medicine prices almost 500 percent.
https://www.phrma.org/graphic/print-ad-hospital-markups

Stopping Ebola

PhRMA  |  From PhRMA

The first EVD outbreaks occurred in remote villages in Central Africa, near tropical rainforests, but the most recent outbreak in west Africa has involved major urban as well as rural areas.
https://www.phrma.org/science/how-far-we-ve-come/progress-in-treating-disease/stopping-ebola

340B Spotlight: New pieces of legislation continue momentum to fix 340B program

PhRMA  |  Blog Post

Congress should pass the 340B PAUSE Act and the HELP ACT so that policymakers can work to fix 340B and ensure patients are benefiting from the program.
http://catalyst.phrma.org/340b-spotlight-new-pieces-of-legislation-continue-momentum-to-fix-340b-program

Patient voices missing from media conversation about prescription drug abuse

PhRMA  |  Blog Post

As the non-profit points out, even a small reduction can significantly change our nation.
http://catalyst.phrma.org/patient-voices-missing-from-media-conversation-about-prescription-drug-abuse

How innovative medicines are benefiting countries across the globe

PhRMA  |  Blog Post

Many countries could save costs with a more competitive generics market.
http://catalyst.phrma.org/how-innovative-medicines-are-benefiting-countries-across-the-globe

Earth Day 2015: Green Initiatives are Good for Business and the Environment

PhRMA  |  Blog Post

BMS, which was one of the pioneers in replacing many solvents with greener alternatives, introduced a green chemistry scorecard to continue to measure its progress.
http://catalyst.phrma.org/earth-day-2015-green-initiatives-are-good-for-business-and-the-environment

Personalized Medicine Can Create Efficiencies in the Health Care System

Chartpack  |  From Our Network

Increased use of molecular diagnostics and targeted therapies can help inform treatment and procedure choices, leading to improved outcomes for patients and savings for the health care system. 
http://chartpack.phrma.org/personal-medicines-in-development-chartpack/benefiting-patients-and-the-health-care-system/personalized-medicine-can-create-efficiencies-in-the-health-care-system

SB 17 doesn’t address pressing prescription drug transparency issues for CA voters

PhRMA  |  Blog Post

PhRMA has convened a national conversation tackling this complex issue, exploring medicine cost trends, the rising cost of chronic disease, insurance coverage of medicine, the role of middlemen and what our industry can do to make medicine more affordable for patients.
http://catalyst.phrma.org/sb-17-doesnt-address-most-pressing-prescription-drug-transparency-issues-for-california-voters

Report Outlines Many New Medicines in Development to Battle Diabetes Epidemic Affecting More than 30 Million Americans

PhRMA  |  Press Release

The full “Medicines in Development for Diabetes” report can be downloaded here. 
https://www.phrma.org/press-release/report-outlines-many-new-medicines-in-development-to-battle-diabetes-epidemic-affecting-more-than-30-million-americans

STEM

PhRMA  |  From PhRMA

STEM: Building a 21st Century Workforce to Develop Tomorrow’s New Medicines, highlights the significant financial and in-kind contributions of the biopharmaceutical industry to STEM education through a broad range of local, state and national initiatives at the K-12 level and beyond.
https://www.phrma.org/media/stem-growing-our-next-generation-of-innovators

Ask About Adherence: Discussion on medication adherence as national priority

PhRMA  |  Blog Post

A well-designed ‘safe harbor’ to the anti-kickback statute can fill an important gap in the current regulations, which have not been updated in years.”
http://catalyst.phrma.org/ask-about-adherence-discussion-on-medication-adherence-as-national-priority

James C. Stansel is new Executive V.P. & General Counsel

PhRMA  |  Press Release

Stansel holds a J.D. from Yale Law School and a Bachelor of Science in economics from Brigham Young University.
https://www.phrma.org/press-release/james-c-stansel-joins-phrma-as-executive-vice-president-and-general-counsel

The Biopharmaceutical Pipeline

PhRMA  |  Report

A new report by the Analysis Group, “The Biopharmaceutical Pipeline: Innovative Therapies in Clinical Development,” examines the state of the drug development pipeline and provides insights into new approaches researchers are pursuing.
https://www.phrma.org/report/the-biopharmaceutical-pipeline

ICYMI Report highlights increasing prevalence for Alzheimer's disease

PhRMA  |  Blog Post

The task is daunting and setbacks have far outnumbered the successes: since 1998, 123 medicines in development for AD have not made it through clinical trials, while only 4 have been approved.
http://catalyst.phrma.org/icymi-report-highlights-increasing-prevalence-for-alzheimers-disease

Driving Innovation and Economic Growth for the 21st Century

PhRMA  |  Report

This report details the continuing rise of state policies and programs to attract, retain, and grow an innovative biopharmaceutical presence.
https://www.phrma.org

PhRMA Statement Following Meeting With President Trump

PhRMA  |  Press Release

"We also talked about how we can work together on health care reform to give consumers more choices and create a more competitive health care marketplace.
https://www.phrma.org/press-release/phrma-statement-following-meeting-with-president-trump

Poll respondents appreciate economic benefits of innovation and call for more protections

PhRMA  |  Blog Post

Increasingly, economists and international organizations are recognizing innovation as one of the most important drivers of economic and social progress and stability. In fact, a re...
http://catalyst.phrma.org/poll-respondents-appreciate-economic-benefits-of-innovation-and-call-for-more-protections

Growth in Prescription Medicine Prices Has Been in Line With Other Health Care Prices

Chartpack  |  From Our Network

Overall growth in prescription medicine prices has been in line with the trend in prices of other components of health care.
http://chartpack.phrma.org/biophrma-chartpack/spending-and-costs/growth-in-prescription-medicine-prices-has-been-in-line-with-other-health-care-prices

Medicare Monday: It is Medicare’s birthday month!

PhRMA  |  Blog Post

We’ve looked at the history of Medicare and broken down the details on our website.
http://catalyst.phrma.org/medicare-monday-it-is-medicares-birthday-month

New Reports Highlight Increasing Global Competition in Biopharmaceutical R&D, Posing Significant Challenges to Future U.S. Standing

PhRMA  |  Press Release

Closing the Gap: Increasing Global Competition to Attract and Grow the Biopharmaceutical Sector identifies countries that are increasingly focused on building their own biomedical R&D and manufacturing infrastructure—with a heavy focus on growing their STEM workforces—in an effort to better compete with the U.S. and encourage critical investments to shift from the U.S. to those countries.
https://www.phrma.org/press-release/new-reports-highlight-increasing-global-competition-in-biopharmaceutical-randd-posing-significant-challenges-to-future-u-s-standing

EFPIA-PhRMA Principles successfully enable responsible clinical trial data sharing

PhRMA  |  Blog Post

Of the 935 requests on which a decision had been made, the vast majority, 80 percent, were approved, showing that considerable data sharing is now taking place.
http://catalyst.phrma.org/efpia-phrma-principles-successfully-enable-responsible-clinical-trial-data-sharing

You have reviewed the first 325 results out of 2151. Each page contains 25 results. You're on page 13.

prev 13 14 15 16 17 18 next